Latest News, Local News, International News, US Politics, Economy

High-Potency Marijuana Exposes Risks of Cannabis-Related Psychiatric Disorders

Anders Gilliand’s journey with marijuana began innocently enough at the age of 14. However, by 17, he started experiencing disturbing symptoms, losing touch with reality. 

His mother, Kristin Gilliand, recalls how he began to believe in communication from higher beings, a sign of delusions often associated with schizophrenia.

Tragic Journeys

Despite the diagnosis and subsequent treatment with anti-psychotic medication, Anders faced challenges with side effects, leading him down a tragic path that ultimately culminated in a fatal heroin overdose at the age of 22.

Kristin Gilliand, a neuroscientist at Vanderbilt University, attributes her son’s descent into psychosis to his early marijuana use. 

While acknowledging a family history of schizophrenia, she believes that Anders’s cannabis consumption triggered psychotic episodes, exacerbating an already predisposed condition.

Anders’s story is not unique. Increasingly, young adults, particularly men, face elevated risks of developing psychosis linked to marijuana use. 

Studies from Denmark and Britain suggest a correlation between heavy marijuana consumption and psychiatric disorders like depression, bipolar disorder, and schizophrenia. 

Experts point to the escalating levels of THC, the psychoactive compound in cannabis, as a significant factor amplifying these risks.

Dr. Christian Thurstone, a child psychiatrist at the University of Colorado School of Medicine, underscores the heightened danger among teenagers, emphasizing the dose-dependent nature of marijuana-induced psychosis. 

He warns that prolonged exposure, especially during adolescence, heightens the risk of severe mental illnesses.

Beyond psychosis, the surge in high-potency THC products raises concerns about addiction. Thurstone highlights the increasing likelihood of developing cannabis use disorder with frequent exposure to potent strains. 

The physical and psychological addictiveness of marijuana, once a subject of debate, is now widely acknowledged, with approximately one in ten users facing addiction, according to the Centers for Disease Control.

Read more: Insight From The Vatican, Document On Gender, Surrogacy, And Human Dignity Set For Release

Exploring Marijuana’s Neurological Interference

Anders Gilliand’s journey with marijuana began innocently enough at the age of 14. However, by 17, he started experiencing disturbing symptoms, losing touch with reality.

The neurological effects of marijuana, particularly its interference with cognitive functions, are well-documented. The surge in potency, with THC levels tenfold higher than decades past, presents new challenges.

As THC levels soar, so do the risks of impaired cognition, memory deficits, and difficulties in problem-solving.

The mechanisms through which marijuana triggers psychosis remain elusive, though scientists suspect its impact on brain function. 

The commercialization of marijuana products, with THC levels surpassing 20%, reflects a concerning trend. Patrick Johnson, a dispensary manager in Colorado, notes the escalating demand for potent strains, mirroring a nationwide pattern following legalization for recreational use in several states.

Mahmoud ElSohly, a cannabis researcher at the University of Mississippi, highlights tolerance as a driving force behind potency escalation. With users requiring higher doses to achieve desired effects, manufacturers are capitalizing on this demand, saturating the market with high-potency products.

As consumers navigate a landscape inundated with potent marijuana strains, questions arise about safety and regulation. The absence of standardized dosing complicates assessments of risk and response. 

Cannabis edibles, typically containing lower THC concentrations than flower buds, represent one avenue for regulation. States like New York are imposing caps on THC content per serving to mitigate potential harm.

Despite concerns, there’s optimism that THC levels will plateau, with regulatory measures curbing excessive potency. However, challenges persist as manufacturers innovate, finding new ways to enhance THC concentrations in products.

As Anders Gilliand’s tragic story illustrates, the potency of marijuana isn’t just about a better high—it’s about the mental health risks it poses, particularly for vulnerable populations. 

As policymakers, researchers, and consumers grapple with these realities, the imperative remains clear: understanding and addressing the complex interplay between marijuana potency and mental health is paramount in safeguarding public well-being.

Read more: California Democrats Stand Firm Against Bill Targeting Loitering Amid Prostitution Surge In Cities

Leave A Reply

Your email address will not be published.